Home The Magnetofection Method: Using Magnetic Force to Enhance Gene Delivery
Article
Licensed
Unlicensed Requires Authentication

The Magnetofection Method: Using Magnetic Force to Enhance Gene Delivery

  • C. Plank , U. Schillinger , F. Scherer , C. Bergemann , J.-S. Rémy , F. Krötz , M. Anton , J. Lausier and J. Rosenecker
Published/Copyright: June 1, 2005
Biological Chemistry
From the journal Volume 384 Issue 5

Abstract

In order to enhance and target gene delivery we have previously established a novel method, termed magnetofection, which uses magnetic force acting on gene vectors that are associated with magnetic particles. Here we review the benefits, the mechanism and the potential of the method with regard to overcoming physical limitations to gene delivery. Magnetic particle chemistry and physics are discussed, followed by a detailed presentation of vector formulation and optimization work. While magnetofection does not necessarily improve the overall performance of any given standard gene transfer method in vitro, its major potential lies in the extraordinarily rapid and efficient transfection at low vector doses and the possibility of remotely controlled vector targeting in vivo.

:
Published Online: 2005-06-01
Published in Print: 2003-05-15

Copyright © 2003 by Walter de Gruyter GmbH & Co. KG

Articles in the same Issue

  1. The Circadian Clock of the Unicellular Eukaryotic Model Organism Chlamydomonas reinhardtii
  2. Cardiovascular Control by the Suprachiasmatic Nucleus: Neural and Neuroendocrine Mechanisms in Human and Rat
  3. Synchronization of the Molecular Clockwork by Light- and Food-Related Cues in Mammals
  4. Identification of Rhythmic Subsystems in the Circadian Cycle of Crassulacean Acid Metabolism under Thermoperiodic Perturbations
  5. Age-Dependent Effects of Conditioning on Cholinergic and Vasopressin Systems in the Rat Suprachiasmatic Nucleus
  6. The Magnetofection Method: Using Magnetic Force to Enhance Gene Delivery
  7. The Protease Inhibitor Bikunin, a Novel Anti-Metastatic Agent
  8. Transcriptional Regulation of the Urokinase Receptor (u-PAR) – A Central Molecule of Invasion and Metastasis
  9. Identification and Characterization of KAT, a Novel Gene Preferentially Expressed in Several Human Cancer Cell Lines
  10. Trichostatin A and Structurally Related Histone Deacetylase Inhibitors Induce 5-Lipoxygenase Promoter Activity
  11. Treatment of Tumor Cells with Histone Deacetylase Inhibitors Results in Altered Recruitment of Methyl-CpG Binding Proteins to a Methylated CpG Island
  12. Intra- and Interspecies Interactions between Prion Proteins and Effects of Mutations and Polymorphisms
  13. Contribution of the Absolutely Conserved B8Gly to the Foldability of Insulin
  14. Fabin, a Novel Calcyon-Like and Glucanase-Like Protein with Mitogenic, Antifungal and Translation-Inhibitory Activities from Broad Beans
  15. Quantification of Elastase-Like Activity in 13 Human Cancer Cell Lines and in an Immortalized Human Epithelial Cell Line by RP-HPLC
  16. Differences in the Activation Mechanism between the α and β Subunits of Human Meprin
Downloaded on 14.10.2025 from https://www.degruyterbrill.com/document/doi/10.1515/BC.2003.082/html?srsltid=AfmBOor6bTW2_nFE8GXMbpE9ROD9LUxKva-PFXbWZgCTyucTrWF5-lrA
Scroll to top button